A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Harmonics Bionics Partnership with Healthlink Holdings

Harmony SHR’s anatomically matched shoulder design allows a larger and more natural range of motion for patients recovering from neurological or musculoskeletal impairments compared to other upper extremity exoskeletons on the market today. Harmony was also built to help facilitate evidence-based principles in a rehab session, such as mirror therapy that has shown to improve outcomes in chronic stroke patients.

“The incidence of stroke in Hong Kong has increased over 50% in the last ten years so we know that there is a need for technology and innovation to help recovering patients,” said Healthlink Holdings Sales & Marketing Director Samuel Chan. “While we have been in the rehabilitation robotics industry for many years, we have never seen an upper extremity device like Harmony SHR that can address both neurological and orthopedic markets with its shoulder functionality and assessment capabilities, so we are excited to help make this available to patients and providers in Hong Kong and Macau.”

“While we are primarily focused on the US market at this stage, we are always looking for partnerships in territories that will help grow the adoption of our technology worldwide,” said Harmonic Bionics CEO Christopher Prentice. “With Healthlink’s existing relationships with public and private hospitals and sports clinics in Hong Kong and Macau, they will be a great ally for Harmonic Bionics.”

More here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy